EV/EBITDA
-0.39
+0.02+4.88%
9 min ago
Summary
- As of February 24, 2025, PRLD EV/EBITDA is -0.39, with a rise of +0.02 (+4.88%) during the most recent trading day.
- Over the past year, PRLD EV/EBITDA has increased by +1.20 (+75.47%).
- PRLD EV/EBITDA is now -8.33% below its all-time high of -0.36.
Performance
PRLD EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PRLD EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +4.9% | -5.2% | -5.9% |
| 1 m1 month | +27.8% | -27.9% | -30.8% |
| 3 m3 months | +9.3% | -10.3% | -11.7% |
| 6 m6 months | +80.8% | -80.9% | -83.9% |
| ytdytd | +23.5% | -24.6% | -27.3% |
| 1 y1 year | +75.5% | -73.9% | -78.2% |
| 5 y5 years | - | - | - |
PRLD EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.54 | +27.8% | |
| 3 m | 3-month | -0.36 | -8.3% | -0.57 | +31.6% |
| 6 m | 6-month | -0.36 | -8.3% | -2.12 | +81.6% |
| 1 y | 1-year | -0.36 | -8.3% | -2.43 | +84.0% |
| 3 y | 3-year | -0.36 | -8.3% | -4.21 | +90.7% |
| 5 y | 5-year | -0.36 | -8.3% | -74.73 | +99.5% |
| alltime | all time | -0.36 | -8.3% | -74.73 | +99.5% |
Prelude Therapeutics Incorporated EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.39(-23.5%) |
| 2024 | -0.51(-70.3%) |
| 2023 | -1.72(-18.9%) |
| Date | Value |
|---|---|
| 2022 | -2.12(-57.5%) |
| 2021 | -4.99(-90.0%) |
| 2020 | -49.96 |
FAQ
- What is Prelude Therapeutics Incorporated EV/EBITDA?
- What is the all time high EV/EBITDA for Prelude Therapeutics Incorporated?
- What is PRLD EV/EBITDA year-to-date change?
- What is Prelude Therapeutics Incorporated EV/EBITDA year-on-year change?
What is Prelude Therapeutics Incorporated EV/EBITDA?
The current EV/EBITDA of PRLD is -0.39
What is the all time high EV/EBITDA for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high EV/EBITDA is -0.36
What is PRLD EV/EBITDA year-to-date change?
Prelude Therapeutics Incorporated EV/EBITDA has changed by +0.12 (+23.53%) since the beginning of the year
What is Prelude Therapeutics Incorporated EV/EBITDA year-on-year change?
Over the past year, PRLD EV/EBITDA has changed by +1.20 (+75.47%)